BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3436360)

  • 1. Interactions between gallamine and muscarinic receptors: allosterism and subpopulation specificity are separate phenomena.
    Ellis J; Seidenberg M
    Eur J Pharmacol; 1987 Nov; 144(1):39-44. PubMed ID: 3436360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quaternary forms of classical muscarinic antagonists distinguish subpopulations of muscarinic receptors: correlation with gallamine-defined subpopulations.
    Ellis J; Lenox RH
    Biochem Biophys Res Commun; 1985 Feb; 126(3):1242-50. PubMed ID: 3977914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gallamine exerts biphasic allosteric effects at muscarinic receptors.
    Ellis J; Seidenberg M
    Mol Pharmacol; 1989 Feb; 35(2):173-6. PubMed ID: 2918854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the interactions of gallamine with muscarinic receptors from brain.
    Ellis J; Lenox RH
    Biochem Pharmacol; 1985 Jun; 34(12):2214-7. PubMed ID: 4004942
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of aging on the interaction of quinuclidinyl benzilate, N-methylscopolamine, pirenzepine, and gallamine with brain muscarinic receptors.
    Surichamorn W; Kim ON; Lee NH; Lai WS; el-Fakahany EE
    Neurochem Res; 1988 Dec; 13(12):1183-91. PubMed ID: 3237310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allosteric regulation of cloned m1-m5 muscarinic receptor subtypes.
    Ellis J; Huyler J; Brann MR
    Biochem Pharmacol; 1991 Oct; 42(10):1927-32. PubMed ID: 1741770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of ligand choice on the apparent binding profile of gallamine to cardiac muscarinic receptors. Identification of three main types of gallamine-muscarinic receptor interactions.
    Lee NH; el-Fakahany EE
    J Pharmacol Exp Ther; 1988 Sep; 246(3):829-38. PubMed ID: 3418516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allosteric effect of gallamine on muscarinic cholinergic receptor binding: influence of guanine nucleotides and conformational state.
    Narayanan TK; Aronstam RS
    Neurochem Res; 1986 Oct; 11(10):1397-406. PubMed ID: 3785535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of d-tubocurarine on rat cardiac muscarinic receptors: a comparison with gallamine.
    Waelbroeck M; Robberecht P; De Neef P; Christophe J
    J Recept Res; 1988; 8(6):787-808. PubMed ID: 3193402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the interaction of gallamine with muscarinic receptor subtypes.
    Michel AD; Delmendo RE; Lopez M; Whiting RL
    Eur J Pharmacol; 1990 Jul; 182(2):335-45. PubMed ID: 2397745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regional distribution of muscarinic receptors preferring gallamine in the rat brain.
    Price M; Messer WS; Hoss W
    Biochem Pharmacol; 1986 Dec; 35(23):4171-6. PubMed ID: 3790147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of chimeric muscarinic receptors to investigate epitopes involved in allosteric interactions.
    Ellis J; Seidenberg M; Brann MR
    Mol Pharmacol; 1993 Sep; 44(3):583-8. PubMed ID: 7690450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gallamine allosterically antagonizes muscarinic receptor-mediated inhibition of adenylate cyclase activity in the rat myocardium.
    Ehlert FJ
    J Pharmacol Exp Ther; 1988 Nov; 247(2):596-602. PubMed ID: 3183955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [3H]N-methylscopolamine dissociation from muscarine receptors affected by low concentrations of allosteric modulators.
    Christopoulos A; Mitchelson F
    Eur J Pharmacol; 1995 Aug; 290(3):259-62. PubMed ID: 7589221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allosteric interactions at the m1, m2 and m3 muscarinic receptor subtypes.
    Lee NH; el-Fakahany EE
    J Pharmacol Exp Ther; 1991 Feb; 256(2):468-79. PubMed ID: 1993991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of acidic amino acids in the allosteric modulation by gallamine of antagonist binding at the m2 muscarinic acetylcholine receptor.
    Leppik RA; Miller RC; Eck M; Paquet JL
    Mol Pharmacol; 1994 May; 45(5):983-90. PubMed ID: 8190113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes of cooperativity between N-methylscopolamine and allosteric modulators alcuronium and gallamine induced by mutations of external loops of muscarinic M(3) receptors.
    Krejcí A; Tucek S
    Mol Pharmacol; 2001 Oct; 60(4):761-7. PubMed ID: 11562438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple binding affinities of N-methylscopolamine to brain muscarinic acetylcholine receptors: differentiation from M1 and M2 receptor subtypes.
    el-Fakahany EE; Ramkumar V; Lai WS
    J Pharmacol Exp Ther; 1986 Aug; 238(2):554-63. PubMed ID: 3755473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneity of binding sites on cardiac muscarinic receptors induced by the neuromuscular blocking agents gallamine and pancuronium.
    Dunlap J; Brown JH
    Mol Pharmacol; 1983 Jul; 24(1):15-22. PubMed ID: 6135150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Competition between positive and negative allosteric effectors on muscarinic receptors.
    Proska J; Tucek S
    Mol Pharmacol; 1995 Oct; 48(4):696-702. PubMed ID: 7476896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.